menu
아주대학교 의학문헌정보센터
검색
All
Title
Author
Keyword / MeSH
Year
Journal Title
Contains
Equals
repository
BROWSE
Communities & Collections
AJOU Authors
Title
Publication Year
Keyword
Keyword (Historical Materials)
Journal
AJOU Open Repository
Browsing by Keyword : Biosimilar Pharmaceuticals
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or enter first few letters:
Sort by:
title
Publication Year
submit date
In order:
Ascending
Descending
Results/Page
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Authors/Record:
All
1
5
10
15
20
25
30
35
40
45
50
Showing results 16 to 22 of 22
Pub Year
Title
Author(s)
2015
Pharmacokinetic and Pharmacodynamic Comparison of Two Recombinant Human Erythropoietin Formulations, PDA10 and Eprex, in Healthy Korean Male Volunteers: A Randomized, Double-Blinded, Single-Dose, Two-Period Crossover Study.
조두연
2022
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18–14/KM10B)
안미선
2021
Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review
김지원
,
서창희
,
정주양
2020
Retention Rate and Efficacy of the Biosimilar CT-P13 Versus Reference Infliximab in Patients with Ankylosing Spondylitis: A Propensity Score-Matched Analysis from the Korean College of Rheumatology Biologics Registry
김현아
2020
Retention rate and long-term safety of biosimilar CT-P13 in patients with ankylosing spondylitis: data from the Korean College of Rheumatology Biologics registry
김현아
2020
Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry
김현아
2018
Switching to biosimilars in the treatment of rheumatic diseases
서창희
1
Browse
Communities & Collections
Ajou Authors
Titles
Publication Year
Keyword
Journal
Guide
아주대학교 의학문헌정보센터
